Evidence map›Paper›PMID 34750583›Full record

ArticleNature cell biology2021

The RNA helicase Ddx21 controls Vegfc-driven developmental lymphangiogenesis by balancing endothelial cell ribosome biogenesis and p53 function.

Katarzyna Koltowska, Kazuhide S Okuda, Marleen Gloger, Maria Rondon-Galeano, Elizabeth Mason, Jiachen Xuan, Stefanie Dudczig, Huijun Chen, Hannah Arnold, Renae Skoczylas and 13 more

Abstract readVideo-Audio Media
PubMed Publisher
In one paragraph

Article in Nature cell biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
2.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Article
  3. RNA Helicase DDX21 Controls CD4Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. DDX24 spatiotemporally orchestrates VEGF and Wnt signaling during developmental angiogenesis.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  11. Ribosome-directed cancer therapies: the tip of the iceberg?Trends in pharmacological sciences · 2025
    Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Regulation of VEGFR3 signaling in lymphatic endothelial cells.Frontiers in cell and developmental biology · 2025
    Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors at 7 institutions in 4 countries.

Katarzyna Koltowska *Division of Genomics of Development and Disease, Institute for Molecular Bioscience, The University of Queensland, St Lucia, Brisbane, Queensland, Australia. kaska.koltowska@igp.uu.se.ORCID http://orcid.org/0000-0002-6841-8900
Kazuhide S Okuda *Division of Genomics of Development and Disease, Institute for Molecular Bioscience, The University of Queensland, St Lucia, Brisbane, Queensland, Australia.ORCID http://orcid.org/0000-0002-8060-0377
Marleen GlogerDepartment of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
Maria Rondon-GaleanoDivision of Genomics of Development and Disease, Institute for Molecular Bioscience, The University of Queensland, St Lucia, Brisbane, Queensland, Australia.
Elizabeth MasonPeter MacCallum Cancer Centre, Melbourne, Victoria, Australia.ORCID http://orcid.org/0000-0002-8823-0024
Jiachen XuanPeter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Stefanie DudczigPeter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Huijun ChenDivision of Genomics of Development and Disease, Institute for Molecular Bioscience, The University of Queensland, St Lucia, Brisbane, Queensland, Australia.
Hannah ArnoldDepartment of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
Renae SkoczylasDepartment of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
Neil I BowerDivision of Genomics of Development and Disease, Institute for Molecular Bioscience, The University of Queensland, St Lucia, Brisbane, Queensland, Australia.
Scott PatersonDivision of Genomics of Development and Disease, Institute for Molecular Bioscience, The University of Queensland, St Lucia, Brisbane, Queensland, Australia.
Anne Karine LagendijkDivision of Genomics of Development and Disease, Institute for Molecular Bioscience, The University of Queensland, St Lucia, Brisbane, Queensland, Australia.ORCID http://orcid.org/0000-0003-1246-1608
Gregory J BaillieDivision of Genomics of Development and Disease, Institute for Molecular Bioscience, The University of Queensland, St Lucia, Brisbane, Queensland, Australia.
Ignaty LeshchinerMassachusetts General Hospital, Harvard-MIT Division of Health Sciences and Technology, Harvard Medical School, Boston, MA, USA.
Cas SimonsDivision of Genomics of Development and Disease, Institute for Molecular Bioscience, The University of Queensland, St Lucia, Brisbane, Queensland, Australia.ORCID http://orcid.org/0000-0003-3147-8042
Kelly A SmithDivision of Genomics of Development and Disease, Institute for Molecular Bioscience, The University of Queensland, St Lucia, Brisbane, Queensland, Australia.ORCID http://orcid.org/0000-0002-8283-9760
Wolfram GoesslingMassachusetts General Hospital, Harvard-MIT Division of Health Sciences and Technology, Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0001-9972-1569
Joan K HeathEpigenetics and Development Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.ORCID http://orcid.org/0000-0001-6955-232X
Richard B PearsonPeter MacCallum Cancer Centre, Melbourne, Victoria, Australia.ORCID http://orcid.org/0000-0001-5919-5090
Elaine SanijPeter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Stefan Schulte-MerkerInstitute of Cardiovascular Organogenesis and Regeneration, Medical Faculty, WWU Münster, Münster, Germany.ORCID http://orcid.org/0000-0003-3617-8807
Benjamin M HoganDivision of Genomics of Development and Disease, Institute for Molecular Bioscience, The University of Queensland, St Lucia, Brisbane, Queensland, Australia. ben.hogan@petermac.org.ORCID http://orcid.org/0000-0002-0651-7065
The University of Queensland · AUThe University of Melbourne · AUUppsala University · SEBroad Institute · USHarvard University · USHubrecht Institute for Developmental Biology and Stem Cell Research · NLRoyal Children's Hospital · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The development of a functional vasculature requires the coordinated control of cell fate, lineage differentiation and network growth. Cellular proliferation is spatiotemporally regulated in developing vessels, but how this is orchestrated in different lineages is unknown. Here, using a zebrafish genetic screen for lymphatic-deficient mutants, we uncover a mutant for the RNA helicase Ddx21. Ddx21 cell-autonomously regulates lymphatic vessel development. An established regulator of ribosomal RNA synthesis and ribosome biogenesis, Ddx21 is enriched in sprouting venous endothelial cells in response to Vegfc-Flt4 signalling. Ddx21 function is essential for Vegfc-Flt4-driven endothelial cell proliferation. In the absence of Ddx21, endothelial cells show reduced ribosome biogenesis, p53 and p21 upregulation and cell cycle arrest that blocks lymphangiogenesis. Thus, Ddx21 coordinates the lymphatic endothelial cell response to Vegfc-Flt4 signalling by balancing ribosome biogenesis and p53 function. This mechanism may be targetable in diseases of excessive lymphangiogenesis such as cancer metastasis or lymphatic malformation.

Indexed as

Cell ProliferationLymphangiogenesisAnimalsAnimals, Genetically ModifiedCell Cycle CheckpointsCells, CulturedCyclin-Dependent Kinase Inhibitor p21DEAD-box RNA HelicasesEndothelial CellsGene Expression Regulation, DevelopmentalHumansHuman Umbilical Vein Endothelial CellsLymphatic VesselsRibosomesRNA, RibosomalSignal Transductioncdkn1a protein, zebrafishCyclin-Dependent Kinase Inhibitor p21DDX21 protein, humanddx21 protein, zebrafishDEAD-box RNA HelicasesRNA, Ribosomaltp53 protein, zebrafishTumor Suppressor Protein p53Vascular Endothelial Growth Factor Cvascular endothelial growth factor C, zebrafishVascular Endothelial Growth Factor Receptor-3Zebrafish Proteins

Identifiers

PMID34750583
OpenAlexW3211845862

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.